US Edition
News from Rush University Medical Center
Top Rush University Medical Center News
Chicago, IL · ChicagoA Study for Patients with Large B-Cell Lymphoma Who have Completed Initial Therapy abernotas Fri, 08/08/2025 - 10:14 Clinical Trial ALLO-501A-202: A Randomized, Open-Label Study Evaluating the Efficacy and Safety of Cemacabtagene Ansegedleucel in Participants with Minimal Residual Disease after Response to First Line Therapy for Large B-Cell Lymphoma (ALPHA3) Rush University Medical Center NCT06500273 This a randomized, open-label study is being…Read Article
A Study for Patients with Large B-Cell Lymphoma Who have Completed Initial Therapy
Cancer · MississippiElevating Patient Care: The Rush and MD Anderson Nursing Collaboration abernotas Tue, 08/05/2025 - 11:52
Melissa Arangoa Miller, MS, APRN, ACNS-BC, AOCNS
.site-wrap.microsite-landing-wrap header .header--secondary ul li, .site-wrap.microsite-basic-wrap header .header--secondary ul li {
width: 195px;
}
In April 2024, Rush Cancer Center formed a partnership with MD Anderson Cancer Center, offering oncology nurses the opportunity to collaborate wi…Read Article
